Purchases and Sales Made in Q4 2024 in Recursion Pharmaceuticals, Inc. (RXRX)
This table provides information about the institutional ownership of Recursion Pharmaceuticals, Inc. (RXRX) during Q4 2024. The information is specifically focused on institutions that hold shares of RECURSION PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 15, 2025
Q4 2024
|
Avanza Fonder Ab
Stockholm, V7 |
BUY
|
- |
85.9KNew |
$489K - $710K
|
85.9K
$551K
|
|
|
Jan 13, 2025
Q4 2024
|
Dbk Financial Counsel, LLC
|
BUY
|
- |
15KNew |
$85.5K - $124K
|
15K
$96.3K
|
|
|
Jan 15, 2025
Q4 2024
|
Arkadios Wealth Advisors
|
BUY
|
- |
12.4KNew |
$70.9K - $103K
|
12.4K
$79.8K
|
|
|
Jan 13, 2025
Q4 2024
|
180 Wealth Advisors, LLC
|
BUY
|
- |
5.46K+ 21.16% |
$31.1K - $45.1K
|
31.2K
$200K
|
|
|
Jan 02, 2025
Q4 2024
|
Gamma Investing LLC
Foster City, CA |
BUY
|
- |
4.95K+ 1979.2% |
$28.2K - $40.9K
|
5.2K
$33.4K
|
|
|
Jan 14, 2025
Q4 2024
|
Decker Retirement Planning Inc.
Levi, UT |
BUY
|
- |
3.86KNew |
$22K - $32K
|
3.86K
$24.8K
|
|
|
Jan 13, 2025
Q4 2024
|
Green Alpha Advisors, LLC
|
BUY
|
- |
2.35K+ 3.62% |
$13.4K - $19.4K
|
67.1K
$431K
|
|
|
Jan 13, 2025
Q4 2024
|
Wedmont Private Capital
|
BUY
|
- |
2K+ 10.56% |
$11.4K - $16.5K
|
20.9K
$134K
|
|
|
Jan 14, 2025
Q4 2024
|
Brave Asset Management Inc
|
BUY
|
- |
1.43K+ 14.33% |
$8.17K - $11.9K
|
11.4K
$73.4K
|
|
|
Jan 02, 2025
Q4 2024
|
Versant Capital Management, Inc
|
BUY
|
- |
1.03K+ 703.4% |
$5.89K - $8.55K
|
1.18K
$7.58K
|
|
|
Jan 06, 2025
Q4 2024
|
Kings Path Partners LLC
Sugar Land, TX |
BUY
|
- |
1K+ 100.0% |
$5.7K - $8.27K
|
2K
$12.8K
|
|
|
Jan 15, 2025
Q4 2024
|
Skopos Labs, Inc.
Riverhead, NY |
BUY
|
- |
724New |
$4.13K - $5.99K
|
724
$4.65K
|
|
|
Jan 14, 2025
Q4 2024
|
Roble, Belko & Company, Inc
Sewickley, PA |
BUY
|
- |
125+ 781.25% |
$713 - $1.03K
|
141
$905
|
|
|
Jan 08, 2025
Q4 2024
|
International Assets Investment Management, LLC
Orlando, FL |
SELL
|
- |
-72.7K- 85.87% |
$414K - $601K
|
12K
$76.8K
|